Determination of levofloxacin by HPLC with fluorescence detection in human breast milk
Abstract
Aim: A new HPLC method with fluorescence detection has been developed and validated for the determination of levofloxacin, one of the fluoroquinolone class antibiotics, in breast milk. Materials & methods: Chromatographic separation was carried out on a reversed phase C18 column with acetonitrile and 10 mM o-phosphoric acid (25:75, v/v) mobile phase composition. Moxifloxacin was used as internal standard and the peaks were detected by fluorescence detection. Results & conclusion: Calibration graph was found linearly within the range of 2.5–500 ng/ml. Limit of detection and limit of quantification were found to be 0.63 and 2.11 ng/ml, respectively. Mean absolute recovery was 96.18%. The developed method has been successfully applied to the determination of levofloxacin in human breast milk taken from two healthy volunteers.
Papers of special note have been highlighted as: • of interest
References
- 1. . Levofloxacin: a therapeutic review. Clin. Ther. 20(6), 1049–1070 (1998).
- 2. Global Alliance for TB Drug Development. Levofloxacin. In: Handbook of Anti-Tuberculosis Agents. Tuberculosis 88(2), 119–121 (2008).
- 3. . Antibiotic use in pregnancy and lactation- what is and is not known about teratogenic and toxic risks. Obstet. Gynecol. 107(5), 1120–1138 (2006). • Gives important data about most of antibiotics.
- 4. . Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial species. Antimicrob. Agents Chemother. 44(12), 3478–3480 (2000).
- 5. . Levofloxacin. a review of ı-its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs 47(4), 677–700 (2012).
- 6. . Breastfeeding and maternal medications. J. Pediatr. 80(5), 189–198 (2004).
- 7. . Use of anti-ınfective agents during lactation: part 2 – aminoglycosides, macrolides, quinolones, sulfonamides, trimethoprim, tetracyclines, chloramphenicol, clindamycin, and metronidazole. J. Hum. Lact. 17(1), 54–65 (2001).
- 8. . Levofloxacin secretion in breast milk: a case report. Pharmacotherapy 25(1), 116–118 (2005). • Gives important data about levofloxacin.
- 9. . Rapid stereospecific high-performance liquid chromatographic determination of levofloxacin in human plasma and urine. J. Pharm. Biomed. Anal. 15(6), 765–771 (1997).
- 10. Determination of levofloxacin in plasma, bronchoalveolar lavage and bone tissues by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method. J. Chromatogr. B 799(1), 165–172 (2004).
- 11. Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector. J. Chromatogr. A 1419, 58–66 (2015).
- 12. Microextraction by packed sorbent and HPLC–PDA quantification of multiple anti-inflammatory drugs and fluoroquinolones in human plasma and urine. J. Enzyme Inhib. Med. Chem. 31, 110–116 (2016).
- 13. . An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum. J. Pharm. Biomed. Anal. 25(2), 197–203 (2001).
- 14. . Pharmacokinetic study of levofloxacin in rat blood and bile by microdialysis and high-performance liquid chromatography. J. Chromatogr. A 961(1), 131–136 (2002).
- 15. . Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma. J. Chromatogr. B 772, 53–63 (2002).
- 16. . Simultaneous determination of levofloxacin and ciprofloxacin in microdialysates and .plasma by high-performance liquid chromatography. Anal. Chim. Acta 463(2), 199–206 (2002).
- 17. . Simultaneous determination of levofloxacin, gatifloxacin and moxifloxacin in serum by liquid chromatography with column switching. J. Chromatogr. B 810, 77–83 (2004).
- 18. . Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies. J. Pharm. Biomed. Anal. 41(4), 1360–1362 (2006).
- 19. . A First liquid chromatography method for the simultaneous determination of levofloxacin, pazufloxacin, gatifloxacin, moxifloxacin and trovafloxacin in human plasma. J. Chromatogr. B 930, 104–111 (2013).
- 20. . Hydrophilic interaction liquid chromatography–tandem mass spectrometry for the determination of levofloxacin in human plasma. J. Pharm. Biomed. Anal. 41(2), 622–627 (2006).
- 21. . Simultaneous determination of rifampicin and levofloxacin concentrations in catheter segments from a mouse model of a device-related infection by liquid chromatography/electrospray ionization tandem mass spectrometry. J. Pharm. Biomed. Anal. 46(4), 723–727 (2008).
- 22. Simultaneous determination of isoniazid,rifampicin,levofloxacin in mouse tissues and plasma by high performance liquid chromatography–tandem mass spectrometry. J. Chromatogr. B 878, 2286–2291 (2010).
- 23. Simultaneous measurement of pazufloxacin, ciprofloxacin, and levofloxacin in human serum by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B 878, 1555–1561 (2010).
- 24. Robust HPLC–MS/MS method for levofloxacin and ciprofloxacin determination in human prostate tissue. J. Pharm. Biomed. Anal. 132, 173–183 (2017).
- 25. . Highly sensitive trivalent copper chelate–luminol chemiluminescence system for capillary electrophoresis chirals eparation and determination of ofloxacin enantiomers in urine samples. J. Pharm. Anal. 4(6), 412–416 (2014).
- 26. . Spectrofluorimetric determination of levofloxacin in tablets, human urine and serum. Talanta 52(6), 1149–1156 (2000).
- 27. . Terbium-sensitized luminescence determination of levofloxacin in tablets and human urine and serum. Analyst 125(10), 1851–1854 (2000).
- 28. . Sequential determination of norfloxaxin and levofloxacin in the presence of other fluorquinolones using synchronous scanning room-temperature phosphorimetry and Th (IV) as the selective signal inducer. Spectrochim. Acta A Mol. Biomol. Spectrosc. 72(2), 429–435 (2009).
- 29. Ag nanoparticles and electrospun CeO2-Au composite nanofibersmodified glassy carbon electrode for determination of levofloxacin. Sens. Actuators. B Chem. 203, 95–101 (2014).
- 30. International Conference on Harmonization. Validation of Analytical Procedures: Text and Methodology Q2(R1) (2005). https://database.ich.org/sites/default/files/Q2_R1__Guideline.pdf
- 31. . An HPLC method for the determination of moxifloxacin in breast milk by fluorimetric detection with precolumn derivatization. Acta Chromatogr. 29(1), 57–65 (2017).